Adding omega-3 fatty acids to anti-tumor medications may improve treatment response and quality of life for cancer patients. The study examined 50 patients with advanced pancreatic cancer and found evidence of activity in response and disease stabilization rates, reduction in liver metastasis volume, and improved quality of life scores in this group of patients.